We read with interest the Article by Kate Duhig and colleagues1 on the use of placental growth factor (PIGF) testing in patients with suspected pre-eclampsia. Although we appreciate the efforts of the authors, we are concerned that their results and interpretation are misleading.
|Number of pages||1|
|Early online date||30 Jan 2020|
|Publication status||Published - 1 Feb 2020|